Towa buys Pensa for €320M

17/01/2020
Diego Gutiérrez
Towa buys Pensa for €320M

Japanese pharmaceutical company Towa Pharmaceutical and the Catalan Esteve today announced an agreement under which Towa will acquire the 100% from Pensa Investments.

This is the Spanish pharmaceutical company's generics division.

The transaction will be carried out for €320 million.

The acquisition is expected to be completed by the end of January 2020.

Corporate finances and movements in the sector are gradually showing the general shift in direction that has been looming for years in the generic drug industry.

Towa Pharmaceutical is a Japanese pharmaceutical company, which has recently acquired the 100% of Pensa Investmentsbelonging to the Spanish pharmaceutical company Esteveby 320M€.

This generics division accounts for a third of the Spanish group's revenues, but it is an operation that forms part of its strategic plan.

La acquisition of companies will be paid in a single upfront cash payment and will be fully closed before the end of January.

INTERNATIONAL EXPANSION

With the acquisition of the Catalan company, Towa will be able to supply high quality, value-added generic medicines to patients not only in Japan, but also worldwide.

It will do so through the production platform specialising in "pellets"Pensa and its network of subsidiaries in Europe and the USA.

In this way, the Japanese firm is beginning to lay the foundations for large-scale international expansion.

In fact, it aims to build a solid global structure that respects and integrates the human resources, culture and technologies of each party.

TOWA PHARMACEUTICAL

Headquartered in Kadoma, Kadoma-based Towa Pharmaceutical, a listed is dedicated since 1951 to research, development, production and marketing of generic medicines.

It has a team of more than 3,100 employees, and its total sales amount to 105,104 million Yen, some €867 million.

PENSA INVESTMENTS

Pensa Investment is the legal entity that provides affiliated pharmaceutical manufacturing facilities..

Founded in 2006, Pensa currently employs around 850 people, 500 of whom work in production and operations.

It is present in 11 countries around the world such as Turkey and the USA, but especially in European markets such as Spain, Portugal, Italy, Germany and the Netherlands.

ESTEVE

It is based in Barcelona and was founded in 1929.

It has around 2,300 professionals, and a presence in Europe, the USA, Mexico and China.

In 2018, it had a turnover of €758m, with a weight of 73% coming from international markets.

DIVESTMENT PLAN

This operation will allow the company to focus on its "core business"and accelerate its transformation into an innovative global specialty pharmaceutical company.

In 2018, as part of its strategic plan, Esteve announced its intention to focus its business on proprietary products and specialised medicine areas.

The divestment of Pensa was therefore a logical first step in its transformation process.

Lastest news

The State of Technology M&A in Spain | October 2026 analysis

En octubre de 2026 hubo 37 operaciones de M&A tecnológico en España: 16 fueron adquisiciones corporativas, inversiones de private equity, fusiones o tomas de participación, y 21 fueron rondas de venture capital. El 62,2% de las operaciones (23 de 37) fueron...

Webinar | How much does your business depend on you?

IMPORTANT INFORMATION: Registration for and participation in the webinars are completely anonymous to third parties. If, for a month, you were unable to have a say in important decisions, what would happen in your company? Your company can grow, be profitable and have good...

Notable technology M&A deals in Spain | September 2026 Analysis

Technology M&A in Spain totalled 61 identified transactions by the end of September 2026, the highest figure in the monthly series we have been publishing since May. Of these, 41 were acquisitions, private equity investments, asset purchases, joint ventures or takeovers...

Baker Tilly advises Invelon on the acquisition of byAR

In September 2026, Invelon, a Spanish technology company specialising in virtual, augmented and mixed reality, completed the acquisition of a majority stake in byAR, a Portuguese company specialising in museum exhibitions and the development of spaces...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

    On which topic would you like to receive information?